Plasmapheresis as preparatory method for thymectomy in myasthenia gravis

To study the effects of plasmapheresis in preparation for thymectomy, two groups of 40 patients were selected from a sample of 286 patients with myasthenia gravis examined by the first author Group 1 included patients (15 male and 25 female; age range 8-64 yrs) who underwent thymectomy without previous plasmapheresis, whereas patients in group 2 (17 male and 23 female; age range 11-61 yrs) were thymectomized after plasmapheresis. We required patients to have a minimum follow-up period of 12 months to be included in the study. A clinical evaluation protocol composed of 76 items was developed for the study. We found significant improvement in respiratory function and muscular strength in patients thymetomized after plasmapheresis. Furthermore, the combined treatment reduced cost and length of hospital stay. Therefore, we conclude that plasmapheresis should be considered as a coadjuvant to thymectomy in the treatment of myasthenia gravis.

Saved in:
Bibliographic Details
Main Authors: Seggia,José Carlos Brant, Abreu,Paulo, Takatani,M.
Format: Digital revista
Language:English
Published: Academia Brasileira de Neurologia - ABNEURO 1995
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X1995000300007
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0004-282X1995000300007
record_format ojs
spelling oai:scielo:S0004-282X19950003000072010-12-09Plasmapheresis as preparatory method for thymectomy in myasthenia gravisSeggia,José Carlos BrantAbreu,PauloTakatani,M. myasthenia gravis thymectomy plasmapheresis To study the effects of plasmapheresis in preparation for thymectomy, two groups of 40 patients were selected from a sample of 286 patients with myasthenia gravis examined by the first author Group 1 included patients (15 male and 25 female; age range 8-64 yrs) who underwent thymectomy without previous plasmapheresis, whereas patients in group 2 (17 male and 23 female; age range 11-61 yrs) were thymectomized after plasmapheresis. We required patients to have a minimum follow-up period of 12 months to be included in the study. A clinical evaluation protocol composed of 76 items was developed for the study. We found significant improvement in respiratory function and muscular strength in patients thymetomized after plasmapheresis. Furthermore, the combined treatment reduced cost and length of hospital stay. Therefore, we conclude that plasmapheresis should be considered as a coadjuvant to thymectomy in the treatment of myasthenia gravis.info:eu-repo/semantics/openAccessAcademia Brasileira de Neurologia - ABNEUROArquivos de Neuro-Psiquiatria v.53 n.3a 19951995-09-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X1995000300007en10.1590/S0004-282X1995000300007
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Seggia,José Carlos Brant
Abreu,Paulo
Takatani,M.
spellingShingle Seggia,José Carlos Brant
Abreu,Paulo
Takatani,M.
Plasmapheresis as preparatory method for thymectomy in myasthenia gravis
author_facet Seggia,José Carlos Brant
Abreu,Paulo
Takatani,M.
author_sort Seggia,José Carlos Brant
title Plasmapheresis as preparatory method for thymectomy in myasthenia gravis
title_short Plasmapheresis as preparatory method for thymectomy in myasthenia gravis
title_full Plasmapheresis as preparatory method for thymectomy in myasthenia gravis
title_fullStr Plasmapheresis as preparatory method for thymectomy in myasthenia gravis
title_full_unstemmed Plasmapheresis as preparatory method for thymectomy in myasthenia gravis
title_sort plasmapheresis as preparatory method for thymectomy in myasthenia gravis
description To study the effects of plasmapheresis in preparation for thymectomy, two groups of 40 patients were selected from a sample of 286 patients with myasthenia gravis examined by the first author Group 1 included patients (15 male and 25 female; age range 8-64 yrs) who underwent thymectomy without previous plasmapheresis, whereas patients in group 2 (17 male and 23 female; age range 11-61 yrs) were thymectomized after plasmapheresis. We required patients to have a minimum follow-up period of 12 months to be included in the study. A clinical evaluation protocol composed of 76 items was developed for the study. We found significant improvement in respiratory function and muscular strength in patients thymetomized after plasmapheresis. Furthermore, the combined treatment reduced cost and length of hospital stay. Therefore, we conclude that plasmapheresis should be considered as a coadjuvant to thymectomy in the treatment of myasthenia gravis.
publisher Academia Brasileira de Neurologia - ABNEURO
publishDate 1995
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X1995000300007
work_keys_str_mv AT seggiajosecarlosbrant plasmapheresisaspreparatorymethodforthymectomyinmyastheniagravis
AT abreupaulo plasmapheresisaspreparatorymethodforthymectomyinmyastheniagravis
AT takatanim plasmapheresisaspreparatorymethodforthymectomyinmyastheniagravis
_version_ 1756374029334216704